Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1975 Apr;55(4):675–680. doi: 10.1172/JCI107976

Alteration of human erythrocyte membrane properties by complement fixation.

J R Durocher, J P Gockerman, M E Conrad
PMCID: PMC301802  PMID: 1120777

Abstract

Erythrocyte survival studies of complement-coated radiolabeled erythrocytes have shown rapid removal of these cells from the peripheral blood with a return of these cells into the circulation within a few hours. We studied complement-coated human erythrocytes and measured surface charge and deformability, two parameters believed to be important in erythrocyte survival. Erythrocytes were coated with complement by two in vitro techniques: the addition of (a) low ionic strength sucrose, and (b) IgM cold agglutinins. Erythrocytes obtained from three patients with cold agglutinin disease were used as a source of in vivo complement-coated cells. No difference was found in surface charge as measured by electrophoretic mobility between erythrocytes from normal subjects and complement-coated erythrocytes from any of the three sources. When deformability was measured by filtration through 3-mum polycarbonate sieves, marked decreases in deformability were found in complement-coated erythrocytes. The filtration returned toward control levels by incubating the complement-coated erythrocytes in serum for 1 h and correlated with decreases in immune adherence. Using screen filtration pressure as a measure of deformability, a positive correlation between number of C3 molecules per erythrocyte and decreased deformability was found. C3b appeared responsible for the decreased deformability of the erythrocytes, since conversion of C3b to C3d resulted in a return of deformability toward normal. The data suggested that the sequestration of complement-coated human erythrocytes in the microvasculature can be explained in part by decreased deformability and changes in immune adherence.

Full text

PDF
675

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson J. P., Frank M. M. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. J Clin Invest. 1974 Aug;54(2):339–348. doi: 10.1172/JCI107769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Borsos T., Leonard E. J. Detection of bound C3 by a new immunochemical methods. J Immunol. 1971 Sep;107(3):766–771. [PubMed] [Google Scholar]
  3. Brown D. L., Lachmann P. J., Dacie J. V. The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits. Clin Exp Immunol. 1970 Sep;7(3):401–421. [PMC free article] [PubMed] [Google Scholar]
  4. Cooper N. R., Müller-Eberhard H. J. The reaction mechanism of human C5 in immune hemolysis. J Exp Med. 1970 Oct 1;132(4):775–793. doi: 10.1084/jem.132.4.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DUMONDE D. C., BITENSKY L., CUNNINGHAM G. J., CHAYEN J. THE EFFECTS OF ANTIBODIES ON CELLS. I. BIOCHEMICAL AND HISTOCHEMICAL EFFECTS OF ANTIBODIES AND COMPLEMENT ON ASCITES TUMOUR CELLS. Immunology. 1965 Jan;8:25–36. [PMC free article] [PubMed] [Google Scholar]
  6. EYLAR E. H., MADOFF M. A., BRODY O. V., ONCLEY J. L. The contribution of sialic acid to the surface charge of the erythrocyte. J Biol Chem. 1962 Jun;237:1992–2000. [PubMed] [Google Scholar]
  7. FORRESTER J. A., DUMONDE D. C., AMBROSE E. J. THE EFFECTS OF ANTIBODIES ON CELLS. II. CHANGES IN THE ELECTROPHORETIC MOBILITY OF ASCITES TUMOUR CELLS TREATED WITH ANTIBODIES AND COMPLEMENT. Immunology. 1965 Jan;8:37–48. [PMC free article] [PubMed] [Google Scholar]
  8. Gregersen M. I., Bryant C. A., Hammerle W. E., Usami S., Chien S. Flow Characteristics of Human Erythrocytes through Polycarbonate Sieves. Science. 1967 Aug 18;157(3790):825–827. doi: 10.1126/science.157.3790.825. [DOI] [PubMed] [Google Scholar]
  9. Güttler F., Clausen J. Changes in lipid pattern of HeLa cells exposed to immunoglobulin G and complement. Biochem J. 1969 Dec;115(5):959–968. doi: 10.1042/bj1150959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hartmann R. C., Jenkins D. E. The "sugar-water" test for paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1966 Jul 21;275(3):155–157. doi: 10.1056/NEJM196607212750308. [DOI] [PubMed] [Google Scholar]
  11. Hesketh T. R., Payne S. N., Humphrey J. H. Complement and phospholipase C lysis of lipid membranes. Immunology. 1972 Nov;23(5):705–711. [PMC free article] [PubMed] [Google Scholar]
  12. Inoue K., Kinsky S. C. Fate of phospholipids in liposomal model membranes damaged by antibody and complement. Biochemistry. 1970 Nov 24;9(24):4767–4776. doi: 10.1021/bi00826a021. [DOI] [PubMed] [Google Scholar]
  13. Kerr R. O., Dalmasso A. P., Kaplan M. E. Erythrocyte-bound C5 and C6 in autoimmune hemolytic anemia. J Immunol. 1971 Oct;107(4):1209–1210. [PubMed] [Google Scholar]
  14. Lay W. H., Nussenzweig V. Receptors for complement of leukocytes. J Exp Med. 1968 Nov 1;128(5):991–1009. doi: 10.1084/jem.128.5.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lichtman M. A., Weed R. I. Electrophoretic mobility and N-acetyl neuraminic acid content of human normal and leukemic lymphocytes and granulocytes. Blood. 1970 Jan;35(1):12–22. [PubMed] [Google Scholar]
  16. Logue G. L., Rosse W. F., Adams J. P. Complement-dependent immune adherence measured with human granulocytes: changes in the antigenic nature of red cell-bound C3 produced by incubation in human serum. Clin Immunol Immunopathol. 1973 Apr;1(3):398–407. doi: 10.1016/0090-1229(73)90056-1. [DOI] [PubMed] [Google Scholar]
  17. MARDINEY M. R., Jr, MUELLER-EBERHARD H. J. MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION. J Immunol. 1965 Jun;94:877–882. [PubMed] [Google Scholar]
  18. Mantovani B., Rabinovitch M., Nussenzweig V. Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG). J Exp Med. 1972 Apr 1;135(4):780–792. doi: 10.1084/jem.135.4.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Miller L. H., Usami S., Chien S. Alteration in the rheologic properties of Plasmodium knowlesi--infected red cells. A possible mechanism for capillary obstruction. J Clin Invest. 1971 Jul;50(7):1451–1455. doi: 10.1172/JCI106629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Okada H., Kojima K., Yoshida T. O., Nishioka K. Electrokinetic behavior of intermediate cells in immune hemolysis. J Immunol. 1972 Jan;108(1):59–64. [PubMed] [Google Scholar]
  21. PHILLIPS G. B., MIDDLETON E., Jr STUDIES ON LYSOLECITHIN FORMATION IN IMMUNE HEMOLYSIS. J Immunol. 1965 Jan;94:40–46. [PubMed] [Google Scholar]
  22. Parpart A. K., Lorenz P. B., Parpart E. R., Gregg J. R., Chase A. M. THE OSMOTIC RESISTANCE (FRAGILITY) OF HUMAN RED CELLS. J Clin Invest. 1947 Jul;26(4):636–640. doi: 10.1172/JCI101847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Petz L., Fudenberg H. H., Fink D. Immune adherence reactions of human erythrocytes sensitized with complement in vitro and in vivo. J Immunol. 1971 Dec;107(6):1714–1722. [PubMed] [Google Scholar]
  24. Polley M. J., Müller-Eberhard H. J., Feldman J. D. Production of ultrastructural membrane lesions by the fifth component of complement. J Exp Med. 1971 Jan 1;133(1):53–62. doi: 10.1084/jem.133.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ruddy S., Austen K. F. C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b. J Immunol. 1971 Sep;107(3):742–750. [PubMed] [Google Scholar]
  26. Schreiber A. D., Frank M. M. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites. J Clin Invest. 1972 Mar;51(3):575–582. doi: 10.1172/JCI106846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schreiber A. D., Frank M. M. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum. J Clin Invest. 1972 Mar;51(3):583–589. doi: 10.1172/JCI106847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Smith J. K., Becker E. L. Serum complement and the enzymatic degradation of erythrocyte phospholipid. J Immunol. 1968 Mar;100(3):459–474. [PubMed] [Google Scholar]
  29. Weed R. I. The importance of erythrocyte deformability. Am J Med. 1970 Aug;49(2):147–150. doi: 10.1016/s0002-9343(70)80069-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES